Dash (Discovery Tools (Healthcare))

Website
Current Valuation
$61.0M
As of June 26, 2025
Total Funding Raised
$17.5M
Last Round
Early Stage VC

$11.0M

Last Funding
Jun 2025

Funding date

Capital Efficiency
3.49x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Dash (Discovery Tools (Healthcare)) is currently valued at $61.0M as of June 26, 2025. The company has raised a total of $17.5M in funding.

Capital Efficiency

With a capital efficiency ratio of 3.49x, Dash (Discovery Tools (Healthcare)) has achieved a valuation that is 3.49 times the total capital raised.

Track Dash (Discovery Tools (Healthcare)) Valuation Updates

Get notified when Dash (Discovery Tools (Healthcare)) raises new funding or valuation changes

Explore More Data
Detailed analysis for Dash (Discovery Tools (Healthcare))

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Dash (Discovery Tools (Healthcare))'s valuation history, funding rounds, and growth metrics.

No credit card required

What is Dash (Discovery Tools (Healthcare)) Worth in 2026?

Dash (Discovery Tools (Healthcare)) is a leading private company in the technology sector. Track Dash (Discovery Tools (Healthcare))'s valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Dash (Discovery Tools (Healthcare)) Valuation is Determined

Private company valuations like Dash (Discovery Tools (Healthcare))'s are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.